UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

Blood cancer journal (New York), 2017-02, Vol.7 (2), p.e520-e520

2017

Volltextzugriff (PDF)

Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha

Annals of internal medicine, 2001-11, Vol.135 (10), p.927

2001

Volltextzugriff (PDF)

Herpes simplex virus latent phase transcription facilitates in vivo reactivation

Virology (New York, N.Y.), 1990, Vol.174 (1), p.117-125

1990

Volltextzugriff (PDF)

Efficacy and Safety of Monthly Oral Ibandronate In Postmenopausal Women With Osteopenia

Journal of clinical densitometry, 2008, Vol.11 (3), p.461-461

2008

Volltextzugriff (PDF)

Efficacy and adverse event profile of monthly oral ibandronate during the first year of the mobile long-term extension study

Journal of clinical densitometry, 2007, Vol.10 (2), p.S217-S217

2007

Volltextzugriff (PDF)

Isolation and Partial Characterization of Nucleocapsid Forms from Cells Infected with Human Cytomegalovirus Strains AD 169 and Towne

Intervirology, 2008-07, Vol.29 (2), p.86-100

2008

Volltextzugriff (PDF)

Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss

Bone (New York, N.Y.), 2009-03, Vol.44 (3), p.418-422

2009

Volltextzugriff (PDF)

Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons

Journal of Virology, 1989-10, Vol.63 (10), p.4455-4458

1989

Volltextzugriff (PDF)

Assessment, by Transcription-Mediated Amplification, of Virologic Response in Patients with Chronic Hepatitis C Virus Treated with Peginterferon α-2a

Journal of Clinical Microbiology, 2001-08, Vol.39 (8), p.2850-2855

2001

Volltextzugriff (PDF)

Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon α for chronic hepatitis C

Journal of hepatology, 2003-07, Vol.39 (1), p.106-111

2003

Volltextzugriff (PDF)

Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a

Journal of clinical microbiology, 2001-08, Vol.39 (8), p.2850-2855

2001

Volltextzugriff (PDF)

Two Avirulent Herpes Simplex Viruses Generate Lethal Recombinants in Vivo

Science (American Association for the Advancement of Science), 1986-11, Vol.234 (4777), p.746-748

1986

Volltextzugriff (PDF)

Pathogenesis of a lethal mixed infection in mice with two nonneuroinvasive herpes simplex virus strains

Journal of Virology, 1988-08, Vol.62 (8), p.3037-3039

1988

Volltextzugriff (PDF)

Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants

Investigative ophthalmology & visual science, 1991-04, Vol.32 (5), p.1558-1561

1991

Volltextzugriff (PDF)

Biological Basis for Virulence of Three Strains of Herpes Simplex Virus Type 1

Journal of general virology, 1987-09, Vol.68 (9), p.2389-2395

1987

Volltextzugriff (PDF)

Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin

Annals of internal medicine, 2004-01, Vol.140 (1), p.72

2004

Volltextzugriff (PDF)

A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neurons

Neuron (Cambridge, Mass.), 1990-09, Vol.5 (3), p.353-360

1990

Volltextzugriff (PDF)

Concurrent cetuximab, cisplatin, and radiotherapy (RT) for loco-regionally advanced squamous cell carcinoma of the head and neck (SCCHN): Updated results of a novel combined modality paradigm

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.5529-5529

2005

Volltextzugriff (PDF)

Predictors of virologic relapse in patients with chronic hepatitis C (CHC) treated with peginterferon alfa-2a (40KD) (pegasys) alone or in combination with ribavirin (copegus)

Journal of hepatology, 2003-04, Vol.38, p.19-19

2003

Volltextzugriff (PDF)

Pathways of viral gene expression during acute neuronal infection with HSV-1

Virology (New York, N.Y.), 1992-07, Vol.189 (1), p.150-160

1992

Volltextzugriff (PDF)

Isolation and partial characterization of nucleocapsid forms from cells infected with human cytomegalovirus strains AD169 and Towne

Intervirology, 1988, Vol.29 (2), p.86

1988

Volltextzugriff (PDF)

Latent Infection Can Be Established with Drastically Restricted Transcription and Replication of the HSV-1 Genome

Virology (New York, N.Y.), 1993-02, Vol.192 (2), p.687-691

1993

Volltextzugriff (PDF)

The MOBILE study long-term extension: progressive improvements in efficacy with oral ibandronate (1500mg) when administered monthly

2007

Volltextzugriff (PDF)

Oral ibandronate (150 mg) continues to be effective and well tolerated when administered monthly: the mobile study long-term extension

2007

Volltextzugriff (PDF)

Influence of baseline patient characteristics on response to one-monthly and daily oral ibandronate therapy: 2-year findings from MOBILE

2006

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(24)
Webseiten
(7)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha

Herpes simplex virus latent phase transcription facilitates in vivo reactivation

Efficacy and Safety of Monthly Oral Ibandronate In Postmenopausal Women With Osteopenia

Efficacy and adverse event profile of monthly oral ibandronate during the first year of the mobile long-term extension study

Isolation and Partial Characterization of Nucleocapsid Forms from Cells Infected with Human Cytomegalovirus Strains AD 169 and Towne

Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss

Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons

Assessment, by Transcription-Mediated Amplification, of Virologic Response in Patients with Chronic Hepatitis C Virus Treated with Peginterferon α-2a

Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon α for chronic hepatitis C

Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a

Two Avirulent Herpes Simplex Viruses Generate Lethal Recombinants in Vivo

Pathogenesis of a lethal mixed infection in mice with two nonneuroinvasive herpes simplex virus strains

Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants

Biological Basis for Virulence of Three Strains of Herpes Simplex Virus Type 1

Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin

A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neurons

Concurrent cetuximab, cisplatin, and radiotherapy (RT) for loco-regionally advanced squamous cell carcinoma of the head and neck (SCCHN): Updated results of a novel combined modality paradigm

Predictors of virologic relapse in patients with chronic hepatitis C (CHC) treated with peginterferon alfa-2a (40KD) (pegasys) alone or in combination with ribavirin (copegus)

Pathways of viral gene expression during acute neuronal infection with HSV-1

Isolation and partial characterization of nucleocapsid forms from cells infected with human cytomegalovirus strains AD169 and Towne

Latent Infection Can Be Established with Drastically Restricted Transcription and Replication of the HSV-1 Genome

The MOBILE study long-term extension: progressive improvements in efficacy with oral ibandronate (1500mg) when administered monthly

Oral ibandronate (150 mg) continues to be effective and well tolerated when administered monthly: the mobile study long-term extension

Influence of baseline patient characteristics on response to one-monthly and daily oral ibandronate therapy: 2-year findings from MOBILE

Suchergebnisse filtern